Many people like to mock celebrities for using the various popular weight loss drugs. “Saturday Night Live” recently did a ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Aetna is a minor player in the health insurance exchange market, and the exchanges are a small segment of the CVS Health ...

CVS will exit Obamacare plans in 2026, affecting 1 million members across 17 states, and close stores amid pharmacy desert ...

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...

Retail health clinics have driven conversation about the convenient and accessible care they could provide since their ...

By TOM MURPHY AP Health Writer CVS Health hiked its 2025 forecast above Wall Street’s expectations after improving Medicare ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

CVS Health Corp. reported a strong start to 2025, with first-quarter revenue climbing 7%, driven by growth across all business segments.

NEW YORK (AP) — Tim Friede has been bitten by snakes hundreds of times — often on purpose. Now scientists are studying his ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...